A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find the recommended dose of ART0380 that can be given safely to participants alone and in combination with gemcitabine or irinotecan * Learn more about the side effects of ART0380 alone and in combination with gemcitabine or irinotecan * Learn more about the effectiveness of ART0380 alone and in combination with gemcitabine or irinotecan
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent wyraził zgodę na udział w badaniu.
- •Wszystkie poprzednie leczenia raka zakończono co najmniej 21 dni wcześniej i pacjent wyzdrowiał z ostrych skutków terapii.
- •Pacjent musi mieć co najmniej jedną zmianę nowotworową widoczną w badaniach obrazowych, którą można ocenić.
- •Wyniki badań krwi, nerek, wątroby i krzepnięcia muszą mieścić się w ustalonych normach.
- •Pacjent musi mieć próbkę tkanki nowotworowej do analizy.
- •Pacjenci muszą stosować skuteczną antykoncepcję przez określony czas.
- •Przewidywany czas życia pacjenta wynosi co najmniej 12 tygodni.
✗ Disqualifies
- •Przed rozpoczęciem leczenia w ramach badania, pacjent musiał zakończyć radioterapię paliatywną co najmniej tydzień wcześniej.
- •Pacjenci z mutacją BRCA lub nowotworem z mutacją BRCA lub HRD dodatnim, dla którego istnieje zatwierdzony inhibitor PARP, powinni byli wcześniej przyjąć takie leczenie, chyba że jest to przeciwwskazane.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 30, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (82)
University of Alabama at Birmingham
Birmingham, United States
Mayo Clinic (Arizona)
Scottsdale, United States
University of Arkansas - Winthrop P. Rockefeller Cancer Institute
Little Rock, United States
USC Norris Comprehensive Cancer Center
Los Angeles, United States
Sansum Clinic
Santa Barbara, United States
Providence Medical Foundation
Santa Rosa, United States
Rocky Mountain Cancer Center
Denver, United States
Sarah Cannon Research Institute at HealthONE
Denver, United States
Florida Cancer Specialists
Fort Myers, United States
Mayo Clinic (Florida)
Jacksonville, United States
Cancer Specialists of North Florida
Jacksonville, United States
Florida Cancer Specialists
Orlando, United States
Florida Cancer Specialists
Sarasota, United States
Florida Cancer Specialists
West Palm Beach, United States
Hope and Healing Cancer Services
Hinsdale, United States
Community Health Network
Indianapolis, United States
Our Lady of the Lake
Baton Rouge, United States
Maryland Oncology Hematology - Primary
Columbia, United States
Minnesota Oncology Hematology
Maple Grove, United States
Mayo Clinic (Minnesota)
Rochester, United States
Washington University
St Louis, United States
Hematology Oncology Associates of Central New York
East Syracuse, United States
Northwell Health Cancer Institute
Lake Success, United States
Oncology Hematology Care Primary
Cincinnati, United States
Taylor Cancer Research Center
Maumee, United States
Stephenson Cancer Center
Oklahoma City, United States
Oregon Health & Science University
Portland, United States
University of Pennsylvania / Abramson Cancer Center
Philadelphia, United States
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization
Philadelphia, United States
Tennessee Oncology, PLLC
Chattanooga, United States
Baptist Cancer Center
Memphis, United States
SCRI Oncology Partners
Nashville, United States
Vanderbilt Medical Center
Nashville, United States
Texas Oncology - Central/South Texas
Austin, United States
Mary Crowley Cancer Research
Dallas, United States
Texas Oncology - Baylor Charles A. Sammons Cancer Center
Dallas, United States
Texas Oncology - Northeast Texas
Flower Mound, United States
Oncology Consultants
Houston, United States
Texas Oncology - San Antonio
San Antonio, United States
Utah Cancer Specialists
Salt Lake City, United States
Virginia Cancer Specialists
Fairfax, United States
Institut Gustave Roussy
Villejuif, France
Institut Bergonie
Bordeau, France
Marseille University Hospital Timone
Marseille, France
Saint-Louis Hospital
Paris, France
Hospital Saint-Antoine
Paris, France
Hospital de la Pitié-Salpêtrière
Paris, France
Hospital General Universitario de Elche
Elche, Spain
H. Parc Tauli
Sabadell, Spain
Hospital Universitario Marques de Valdecilla
Santander, Spain
Next Oncology Barcelona, IOB
Barcelona, Spain
Hospital Arnau de Vilanova
Lleida, Spain
Hospital Universitario La Paz
Madrid, Spain
Next - Hospital Quironsalud Madrid
Pozuelo de Alarcón, Spain
Hospital Clínico Universitario Virgen de la Arrixaca
El Palmar, Spain
Clínica Universidad de Navarra
Madrid, Spain
Hospital Clínico Universitario de Santiago (CHUS)
A Coruña, Spain
Hospital Teresa Herrera (CHUAC)
A Coruña, Spain
Institut Català d'Oncologia Badalona - Hospital Germans Trias i Pujol
Badalona, Spain
Vall d'Hebron Institute of Oncology (VIHO)
Barcelona, Spain
Hospital Clinic de Barcelona
Barcelona, Spain
ICO Hospitalet
Barcelona, Spain
Hospital Universitario Reina Sofia de Córdoba
Córdoba, Spain
Hospital Universitari Doctor Josep Trueta- ICO de Girona
Girona, Spain
Hospital General Universitario Gregorio Marañón
Madrid, Spain
MD Anderson Cancer Center (Madrid
Madrid, Spain
Hospital Clinico San Carlos
Madrid, Spain
START Madrid Fundacion Jimenez Diaz
Madrid, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
START Madrid (Hospital San Chinarro)
Madrid, Spain
Hospital Universitario Virgen de la Victoria
Málaga, Spain
Hospital Universitario De Navarra
Pamplona, Spain
START Rioja
Rioja, Spain
Hospital Virgen Macarena
Seville, Spain
Hospital Virgen del Rocío
Seville, Spain
Instituto Valenciano de Oncología (IVO)
Valencia, Spain
Incliva Biomedical Research Institute, University of Valencia
Valencia, Spain
Hospital Universitario Miguel Servet
Zaragoza, Spain
Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Sarah Cannon Research Institute UK
London, United Kingdom
The Christie NHS Foundation Trust - The Christie Clinic
Manchester, United Kingdom
Trial contact
Sarah Cannon Development Innovations
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/31/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.